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Abstract To identity immunodiagnostic antigen genes, a
Plasmodium falciparum (Dd2 clone) expression library
was screened using human immune sera. The ring-infected
erythrocyte surface antigen (RESA) was isolated: this
antigen of the resistant clone presents repeat tandem
sequences like the 3D7 clone, albeit in different numbers.
RESA has been studied as a marker of genetic diversity,
with different sizes being observed in different isolates and
clones of Plasmodium falciparum. The native protein was
localised in cultures by western-blot and immuno-trans-
mission electron microscopy. The antigenicity of RESA
was evaluated by ELISA, using the carboxy-terminal
repeat region as antigen. The assay’s sensitivity and
speciﬁcity were 78.2 and 94% respectively.
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Introduction
Falciparum malaria is one of the most deadly and far-
reaching human health problems throughout the tropical
world. Antimalarial drugs are now considered to be a pow-
erful treatment. Nevertheless, there are Plasmodium falci-
parum (P. falciparum) parasites that are resistant to drugs
that are currently being used in different parts of the world.
Although the protective immune response against intra-
erythrocytic stages of the falciparum malaria parasite is still
notfullyunderstood,immuneantibodieshavebeenshownto
be associated with reduced parasite prevalence [1].
The malaria parasite, P. falciparum, spends part of its
life cycle inside the enucleated erythrocytes of its human
host, which are cells that lack their own machinery for
protein synthesis and trafﬁcking. As a consequence, an
unusual and highly specialised secretory system is needed
to target parasite proteins at their correct destinations.
Indeed the parasite achieves the targeting of proteins,
directing them not only to compartments within its own
conﬁnes but also to the parasitophorous vacuole (PV) in
which it resides and onwards to the PV membrane, the
erythrocyte cytoplasm, and the host cell membrane [2, 3].
The antigenic variation is a survival mechanism devel-
oped by the malaria parasite P. falciparum in order to allow
for the establishment of a chronic infection [4]. After
invading human erythrocytes, the malaria parasite, P. fal-
ciparum, exports proteins beyond the conﬁnes of its own
plasma membrane to modify the properties of the host red
cell membrane. These modiﬁcations are critical to the
pathogenesis of malaria. Analysis of the P. falciparum
genome sequence has identiﬁed a large number of mole-
cules with putative atypical signal sequences. The signals
remain poorly characterised, yet a number of molecules
with these motifs are localised in the host erythrocyte [5].
Coppel et al. [6] described a cloned polypeptide of P.
falciparum representing part of an antigen found at the
surface of erythrocytes infected with ring-stage parasites.
The ring-infected erythrocyte surface antigen (RESA)
contains two separate blocks of tandem repeat sequences
that encode antigenic determinants recognised by anti-
bodies in the sera of individuals exposed to malaria [7].
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amount of attention in malaria research. As it is not possible
for malaria vaccines to be based on the use of killed or
attenuated organisms, the vaccines that are being developed
are subunit vaccines in which the immunogens consist of
deﬁned parasite antigens or antigenic fragments [8]. Frag-
ments of RESA have been used to protect Aotus monkeys
against overwhelming infection with P. falciparum. This
proteinhasbeenidentiﬁedaspotentialvaccinecomponent[9].
Several trials of blood (asexual)-stage vaccines are under
development, but only one (MSP/RESA, also known as
Combination B) has been tested in randomised controlled
trials. The MSP/RESA vaccine shows promise as a way of
reducing the severity of malaria episodes [10]. The Pexel
motif is conserved in Plasmodium spp. Although many
exported proteins are prime candidates for vaccine develop-
mentortherapeuticintervention,theirusefulnessislimitedby
antigenic variation and strain-speciﬁc differences [11].
Ring-infected erythrocyte surface antigen was detected
by immunoelectron microscopy in the erythrocyte mem-
brane infected with ring-stage parasites but not in associ-
ation with immature parasites within the erythrocyte [12].
RESA is found in all ﬁeld isolates of P. falciparum, sug-
gesting that it facilitates survival of the parasite in vivo
[13]. This protein is produced in the ﬁnal stages of schizont
development and is stored in apical organelles, known as
dense granules, within the individual merozoites [14].
Following rupture and reinvasion of a new red blood cell
by a merozoite, RESA is secreted into the newly formed
PV and then transported, by an unknown mechanism, to the
red cell membrane skeleton [15]. The interaction of RESA
with erythrocyte spectrin has been shown to stabilise the
erythrocyte membrane [16, 17] and may be involved in
repair of the host membrane following invasion.
In this report, we describe the cloning of P. falciparum
RESA, isolated from cDNA expression constructed using
erythrocytic stages of Dd2 resistant clone (chloroquine,
meﬂoquine and pyrimethamine), and conﬁrm its property
as an immunogenic molecule for diagnosis of malaria.
Genetic diversity was studied, and different degrees of
diversity of RESA gene sequences were found among P.
falciparum patient’s isolates and different strains. RESA
was localised at erythrocytes stages of P. falciparum, Dd2
clone, by immunoelectron microscopy (IEM) and scanning
electron microscopy (SEM).
Materials and methods
Parasites
Plasmodiumfalciparumwasobtainedfrominvitrocultureof
humanbloodcells.Thefollowingwereused:clone3D7from
WestAfrica, derivedfromthecloneNF54[18]andsensitive
to most antimalarial drugs; and clone Dd2 from South-east
Asia,derivedfromtheIndochinaIII/CDCcloneandresistant
to chloroquine, meﬂoquine and pyrimethamine [19].
Human sera
Positive sera
A total of 110 sera were collected from individuals infected
with IFA-conﬁrmed malaria.
Negative sera
To set suitable cut-off values for the assays, we used: 34
sera from healthy Spanish individuals who had had no
contact with endemic areas; and 30 sera from individuals
who had other serologically conﬁrmed parasitic diseases,
such as leishmaniasis (n = 10), Chagas disease (n = 10)
and toxoplasmosis (n = 10).
Equal volumes of sera from individuals infected with
malaria, diagnosed by microscopy and IFA, were collected
from different geographic areas. These were then pooled
and used for screening the cDNA library prepared from P.
falciparum haematic stages. All sera were supplied by the
Parasitology Department of the National Microbiology
Centre (Carlos III Institute of Health).
Cultures
Plasmodium falciparum Dd2 was maintained in culture, in
human erythrocytes incubated at 37C in RPMI 1640
medium with human serum and gas mixture (3% carbon
dioxide ? 1% oxygen ? 96% nitrogen). Fresh human
erythrocytes were added at 3–4 day intervals. The parasites
continued to reproduce in their normal asexual cycle
approximately every 48 h.
Isolates of patients
To study the genetic diversity of P. falciparum, we used
RESA isolatedfrom malariapatients indifferent geographic
areas. Sample collection was undertaken in 2006. Diagnosis
of P. falciparum was conﬁrmed by semi-nested, multiplex
polymerase chain reaction (PCR) [20]. All samples were
supplied by the Parasitology Department of the National
Microbiology Centre (Carlos III Institute of Health).
Enrichment of parasite-infected red blood cells
by the magnetic method
One millilitre of the 10% suspension of erythrocytes was
applied to an LD column assembled in a magnetic unit
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fered saline pH: 7.3 (PBS) to remove non-infected eryth-
rocytes and white blood cells (WBCs). After the efﬂuent
from the column became almost colourless, the magnet was
removed, the cells retained in the column were eluted with
1 ml PBS, and the parasite-infected red blood cells
(PRBC)-enriched fraction was thus obtained. Percentages
of PRBCs to total red blood cells were ascertained, and the
WBC/PRBC ratio was determined after Giemsa staining of
the smear [21].
Extraction of genomic DNA
Plasmodium falciparum genomic DNA (gDNA) was
extracted from blood-stage parasites, Dd2 and 3D7 strains
cultured in vitro, and isolates of malaria patients. The
parasites were resuspended with 400 ll of extraction buffer
(100 mM Tris–HCl, pH 7.4, 100 mM NaCl, 10 mM
EDTA, pH 8.0). Then 1% SDS and K-Proteinase were
added and incubated for 2 h at 55C. After incubation,
RNAse (100 lg/ml) was added and left to react for 1 h at
55C. 0.1 volume of potassium acetate was added and
incubated in ice for 55 min. The DNA was extracted and
precipitated with phenol/chloroform and ethanol respec-
tively. The pellet was resuspended in Milli-Q sterile water
(Millipore), the DNA concentration was determined by a
spectrophotometer, and the samples were stored at -20C.
cDNA expression library
Total RNA was prepared from P. falciparum erythrocyte
stages (Dd2 clone), as previously described [22]. mRNA
was extracted as described by Avid and Leder [23]. A
sample containing 2.2 lg mRNA was converted into dou-
ble-stranded cDNA with the ZAP Express cDNA synthesis
kit (Stratagene, CA, USA) according to the manufacturer’s
instructions, and then ligated to the ZAP expression vector
using the k-ZAP Express library kit (Stratagene). The ori-
ginal library was ampliﬁed so as to contain 4.2 9 10
8 pfu/
ml and 31% of non-recombinant phage.
Isolation and sequence analysis of P. falciparum RESA
cDNA
The cDNA library was screened using equal volumes of
sera from individuals infected with malaria, diagnosed by
microscopy and IFA, collected from different geographic
areas. The screening yielded several promising signals, 14
of which were puriﬁed by repeated cycles of immuno-
screening. Recombinant pBK-CMV plasmids were excised
from positive phages. The size of the cDNA inserts were
determined by PCR with T3 and T7 pBK-CMV primers
and EcoRI/XhoI double digestions. The nucleotide
sequences were determined by the dideoxy method [24],
using the Big-Dye Terminator Cycle Sequencing Ready
Reaction Kit (Perkin Elmer, Langen, Germany) and an
Applied Biosystems 377 DNA sequencer (Perkin Elmer).
An insert of 1,336 pb, which showed a high degree of
similarity to RESA, was selected. DNA sequence and
predicted amino acid sequence comparisons were per-
formed with the EMBL and SWISS-PROT databanks,
using software packages from Genetic Computer Group
[25]. The primers were synthesized by Roche Molecular
Biochemicals, Barcelona, Spain. The PCR experiments
were performed on a GeneAmp PCR System 2400 (Perkin
Elmer, NJ, USA).
Genetic diversity in RESA
The study of genetic diversity was based on isolates of
malaria patients from different geographic areas and 3D7
and Dd2 clones. DNA (gDNA) was extracted from blood-
stage parasites as previously described. PCR ampliﬁcation
was performed for RESA. The primers used, forward pri-
mer 50-ATATAGAAGAAAATGTGC-30 and reverse pri-
mer 50-ATTCATCATATTCTTCGTT-30, were conserved
in all isolates.
Preparation of rabbit RESA-speciﬁc antiserum
Two 3-month-old female New Zealand white rabbits were
immunised by subcutaneous injection of 200 lg of the
recombinant puriﬁed protein (RESACt) in Freund’s com-
plete adjuvant (Difco
). Before the ﬁrst immunisation,
10 ml were obtained from each rabbit as negative control.
Animals were boosted twice with 200 lg of RESACt
puriﬁed in Freund’s incomplete adjuvant (Difco
),
6 weeks post-intramuscular injection. 15 days after the
third immunisation, the animals were bled. The serum
obtained will be referred to here as anti-RESACt. Serum
titre was determined by ELISA.
SDS-PAGE and western blot analysis
One-dimensional sodium dodecyl sulphate-polyacrylamide
gel electrophoresis (SDS-10%PAGE) and western blotting
of P. falciparum Dd2 clone protein extract (20 lg) were
performed. The separated proteins were transferred to
nitrocellulose membranes (Schleicher & Schuell, Protran
)
with a semi-dry blotting apparatus (Trans-blot
 SD Semi-
dry, Bio-Rad
) for 30 min at 10 V. Thereafter, the ﬁlters
were blocked overnight with PBS containing 3% BSA
(PBS–BSA) at 4C. The following day, they were rinsed in
PBS containing 0.05% (w/v) Tween
 20, and incubated
with anti-RESACt polyclonal rabbit antiserum diluted
1/500 in the blocking solution, for 1 h at room temperature.
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oxidase (H and L chains) (Pierce) diluted 1/5,000 was
added and incubated for 1 h at room temperature. The
nitrocellulose membrane was washed and the reaction
developed with DAB substrate diluted in peroxide buffer
(Pierce
), as described in the manufacturer’s instructions.
Immuno-transmission electron microscopy
For immunogold detection of RESA plasmodium protein in
ultrathin sections, the cells were ﬁxed in 2% paraformal-
dehyde, 0.2% glutaraldehyde in 0.1 M Sodium Cacodylate
buffer, for 60 min at 4C, rinsed (2 9 30 min) in chilled
0.1 M Sodium Cacodylate buffer supplemented with 4.5%
sacarose, and treated for low-temperature embedding in
hydrophilic acrylic resin (Lowicryl K4M—Polyscience,
Warrington, PA) to preserve the antigen properties. Brieﬂy,
the samples were dehydrated, starting with 50% ethylene
glycol at 0C and followed by a graded ethanol (50–90%)
series at -35C, embedded in a 90% ethanol/Lowicryl
series graded through to pure Lowicryl resin, and poly-
merised with a UV light at -35C and at room tempera-
ture. Ultrathin sections, obtained with an ultramicrotome
(Ultratome, LKB), were mounted on 400-mesh nickel grids
and processed for immunogold-labelling at room temper-
ature, blocked (39) in 100 ll drops of blocking buffer
(TBS 10 mM Tris–HCl, 9 mg/ml NaCl, pH 7.4; 0.2 mg/ml
NaN3; 0.1% Tween 20, 20 mg/ml BSA), incubated for
60 min on a 10 ll drop of primary antibodies (anti-RESA
rabbit speciﬁc antiserum, 1/5,000 in blocking buffer),
washed (39) in 100 ll drops of washing buffer (TBS–
NaN3–Tween; 2 mg/ml BSA), incubated for 60 min on
10 ll drops of secondary antibodies (goat anti-rabbit IgG
coupled to 10-nm-diameter colloidal gold particles—Bio-
cell Amersham Pharmacia-Biotech—diluted 1/10 in
washing buffer), and washed 39 (washing buffer ?0.1%
Triton X-100) plus 39 in dd water. To contrast the sec-
tions, uranyl acetate (1% in dd water) was used. The
samples were analysed in TEM mode under a CM-12
TEM/STEM Philips Electron Microscope.
Expression and puriﬁcation of carboxyl-terminal
fragment (Pfal-RESACt) of P. falciparum RESA
The carboxyl-terminal fragment (RESACt 481-951aa) of
the P. falciparum RESA cDNA coding sequence was
ampliﬁed by PCR with the forward primer 50-GAGAGA-
GAGAATTCAAGAAAATGTGC-30 and the reverse pri-
mer 50-GAGAGAGACTCGAGTTATTCATCAT-30. The
primers were synthesized by Roche Molecular Biochemi-
cals, Barcelona, Spain. The PCR experiments were per-
formed on a GeneAmp PCR System 2400 (Perkin Elmer,
NJ, USA). The PCR product of RESACt was directly
subcloned in the EcoRI and XhoI sites of the expression
plasmid vector pGEX-4T-2 (Amersham-Pharmacia-Biotec,
Barcelona, Spain), downstream of the glutathione S-trans-
ferase (GST) coding sequence. Recombinant GST-fusion
protein was expressed in Escherichia coli BL21, after
induction with 1 mM isopropyl-b-D-thiogalactopyranoside
(IPTG;Sigma,Madrid,Spain).Bacterialcultureswerelysed
using B-PER Bacterial Protein Extractor Reagent (Pierce
Cheshire, UK), analysed by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE), and the
expressedproteinswere puriﬁedbyafﬁnitychromatography
with glutathione sepharose 4B, as described by the manu-
facturer (Amersham-Pharmacia-Biotec). The puriﬁed pro-
tein was checked by SDS-PAGE and Coomassie blue
staining, and protein concentration was determined by
bicinchoninic acid (BCA) protein assay (Pierce).
Synthesis of peptides derived from the deduced RESA
amino acid sequence
Taking into account the partial length of the cloned RESA,
theaminoacidsequencewasdeducedandﬁvepeptideswere
designed according to the Jameson–Wolf antigenicity index
[26]. The peptides were synthesised by the National Micro-
biology Centre (Carlos III Institute of Health), and their
sequences were as follows: RESA ZR 165EENVEENV-
EENVEENV180; RESA ZR1 217EENVEENVEENIEE-
NI232; RESA ZR2 221EENVEENIEENIEENA236; RESA
ZR3 253EENIEENIEENIEENI268;a n dR E S AZ R 4281EEN
VEENVEENAEENA296.
ELISA with recombinant protein Pfal-RESACt
and peptides RESA ZR, RESA ZR1, RESA ZR2,
RESA ZR3 and RESA ZR4
Pfal-RESACt (1 lg/ml, 100 ll/well), GST (as a negative
control) and peptides (0.2 lg/ml, 100 ll/well) were diluted
in coating buffer (0.1 M carbonate/bicarbonate pH 9.6) and
then used to coat 96 well plates (MaxiSorp
 2, ﬂat bottom,
Nunc) overnight at 4C. Unbound antigen was removed by
washing the wells with phosphate-buffered saline, pH: 7.3
(PBS) containing 0.05% (w/v) Tween
 20. Free binding
sites were blocked with 3% (w/v) bovine serum albumin
(BSA) (Sigma) 3% diluted in PBS containing 0.01% (w/v)
sodium azide for 1 h at 37C. After washing, 100 llo f
experimental serum samples (diluted 1/100) per well were
added and incubated for 1 h at 37C. Each sample was run
in duplicate. After washing, 100 ll per well of goat anti-
human IgG conjugated with peroxidase (H and L chains,
Pierce
) diluted 1/5,000 were added and incubated for 1 h
at 37C. The plates were washed and 100 ll/well of sub-
strate (ABTS in 10 ml citrate–phosphate–perborate buffer)
was added and the plates were incubated for 15 min at
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microplate reader (Mios, Merk
). A sample was consid-
ered positive if the speciﬁc optical density (OD) value was
greater than the cut-off values. The cut-off value was
obtained with the mean value of 34 negative serum samples
plus 3 standard deviations (SD) (cut-off values: Pfal-
RESACt = 0.123).
Results and discussion
Bioinformatic analysis
Ring-infected erythrocyte surface antigen proteins possess
a PEXEL motif, a pentameric motif present in the N-ter-
minal portion. It consists of a positively charged, hydro-
philic amino acid in position 1 (Arg or Lys), a hydrophobic
amino acid in position 3 (Leu or Ile), and another, less
conserved amino acid in position 5 (predominantly Asp,
Glu or Gln), with no charged amino acids in positions 2 and
4[ 11]. The motif is required for export of soluble proteins
in P. falciparum (supporting data in [11]), being needed to
transport proteins across the parasitophorous vacuole
membrane and into the erythrocyte.
This sequence is functionally conserved in the genus
Plasmodium, indicating the presence of a conserved export
mechanism across the parasitophorous vacuole membrane
in malaria parasites. The PEXEL sequence has made it
possible to predict the export into the host erythrocyte of
proteins that are likely to be important in terms of eryth-
rocyte remodelling and virulence. The availability of gen-
ome sequences from many different species of the genus
Plasmodium now provides an opportunity for genus-wide
discovery of exported proteins and identiﬁcation of speciﬁc
protein domains representing conserved functions in these
different organisms [27].
The PHIST protein family, identiﬁed by Sargeant et al.
[27], is organised into three subfamilies. Of these, PHISTc
is entirely shared between the P. falciparum and P. vivax
lineages, and, in single-copy form, among the three species
of the P. berghei lineage. The PHISTb subfamily appears
to contain only two members in P. vivax and P. knowlesi,
but has radiated extensively in P. falciparum. The PHISTb
subfamily contains a P. falciparum-speciﬁc subgroup
including RESA, which is distinguished by the additional
presence of a DnaJ domain. In eukaryotic cells, proteins
carrying a J-domain act as co-chaperones, regulating the
activity of 70 kDa heat-shock proteins (HSP70s). Three
classes of J-proteins (also called HSP40s) are distinguished
by the presence and nature of the three domains originally
identiﬁed in the bacterial protein DnaJ. Type-I members
contain all three domains, namely, the J-domain (including
a highly conserved HPD motif essential for interaction
between the protein and HSP70), a glycine-rich domain and
a carboxy-terminal zinc-ﬁnger domain.
Unlike PHISTb and PHISTc, PHISTa is entirely P.
falciparum-speciﬁc. It is difﬁcult to assign possible func-
tions to PHIST proteins because none of the members of
this family has previously been described (apart from the
unusual RESA), and the helical structure of the prototyp-
ical PHIST domain appears dissimilar to any known
structure. It is clear, however, that whereas PHISTc per-
forms a function which is common to the genus Plasmo-
dium but is expanded in the P. falciparum and P. vivax
lineages, the function of PHISTa is speciﬁc to P. falcipa-
rum. Proteomic data show a consistent presence of PHIST
proteins in parasite-infected erythrocytes [27].
Isolation and analysis of P. falciparum RESA cDNA
To identify immunodiagnostic antigen genes, a screening of
5 9 10
4 clones from P. falciparum cDNA library (Dd2
clone) with a mix of malaria patient sera yielded 35 prom-
ising signals. Of these, 14 were puriﬁed, excised into pBK-
CMV phagemid and sequenced. All corresponded to the
same molecule but with different sizes. The largest insert
consisted of 1,336 bp, with a putative open reading frame of
936 bp which coded for the putative protein with 317 amino
acidresidues.Themoleculedisplayedapossiblestartcodon,
stop codon and UTR 30. The primary structure amino acid
sequence showed a central domain which contains 34
imperfect repeats with a consensus sequence EENV/I/A
(positions 165–300). This domain comprises four repeats of
the tetramer sequence that is repeated seven times in block.
The majority of malaria antigens contain short sequence
repeats which encode antigenic epitopes that are naturally
immunogenic. Synthetic peptides have been used to con-
ﬁrm the natural immunogenicity of epitopes encoded
within two blocks of related repeats in the antigen RESA.
A 16-amino acid peptide, comprising four repeats of the
tetramer sequence EENV, induced antibodies that were
reactive with the native molecule. Detailed analyses of
these anti-peptide antisera indicate that short sequence
repeats express more than one epitope, some of which may
cross-react with other repeat structures [28].
Alignments of the P. falciparum DNA sequence, and the
amino acid sequence predicted with the Genbank/EMBL
and SWISSPROT databanks show similarity to the protein
RESA (3D7 clone) in 14 promising signals. The other
DNA sequences display similarity to CSP (circumspor-
ozoite protein), MESA (mature parasite-infected erythro-
cyte surface antigen), HSP (heat shock protein) 70 and
RHOPTRY (rhoptry protein). Comparison between the
incomplete protein and the different proteins published in
databanks indicated a 44–98% match (Fig. 1). The
remarkable level of antigenic diversity among different
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123Fig. 1 Alignment of different antigens RESA in different isolates of
P. falciparum and P. yoelii. Comparison of RESA sequences: RESA
(Dd2), incomplete sequence of resistant clone to chloroquine,
meﬂoquine and pyrimethamine, coming from Southeast of Asia;
RESA (3D7), sensible clone coming from African West; 7 RESA-like
genes, isolated 3D7 (RESA hypothetical protein, RESA precursor,
RESA-like protein, RESA-like protein putative, RESA-like protein
truncated); RESA (NF7), coming from Ghana; RESA (FC27), coming
from Papua Nueva Guinea and Plasmodium yoelii RESA. In boxes are
marked identical amino acids
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123strains of P. falciparum [29, 30] reﬂects, at least in part, the
repeat structure of these with an incomplete sequence of
the exon 2 from the Dd2 RESA. The RESA gene shows
two exons separated by one intron [31]. The exon 2 of both
clones presents repeat tandem sequences but in different
numbers. P. falciparum contains polypeptides with
sequence repeats, the extent of which is sometimes
extraordinary. These repeats are immunodominant in the
sense that much of the human antibody response is directed
against them. Many non-immune individuals have been
observed to have very high levels of antibodies to many
repetitive antigens [32].
The genes encoding the three PHIST subfamilies are
located in subtelomeric regions of all chromosomes other
than chromosome 3 [27].
Genetic diversity in RESA
Genetic diversity was studied using PCR, with primers
selected from highly conserved regions that ﬂanked the
tandem repeat regions (variable region) of the highly
polymorphic cell surface antigen, RESA. We used 28
positive P. falciparum-infected samples of malaria patients
from different geographical areas (in Africa—mainly
Equatorial Guinea—Asia and America). Of these, 21,
which came from Equatorial Guinea, Nigeria, Mali, Gabon
and Ivory Coast, were shown to be positive by PCR.
Variation in the size of the ampliﬁed products was
observed in different isolates of P. falciparum and in the
two clones used (3D7 and Dd2; Fig. 2). Several studies use
the same methodology with different polymorphic cell
surface antigens (MSP-1, MSP-2, CSP and RESA) from
positive P. falciparum-infected ﬁeld samples. Neverthe-
less, variation in the size of the ampliﬁed products was
observed using MSP-1 and MSP-2 speciﬁc primers in
different ﬁeld isolates of P. falciparum, but CSP and RESA
displayed no variation in size of the ampliﬁed products
[33]. Some differences were, however, observed in the size
of ampliﬁed fragments. Other authors, using MSP-1 and
MSP-2, have reported that ampliﬁed products varied in size
and that there was speciﬁc pattern for each isolate [34].
Localisation of RESA native protein in extract cultures
from P. falciparum
The immunogenicity of recombinant RESA was analysed
using extracts cultured from P. falciparum Dd2 clone, with
sera from rabbits immunised with the recombinant poly-
peptide. As shown in Fig. 3, sera from polypeptide-im-
munised rabbits immunoprecipitated a polypeptide of
approximately 155 kDa, the apparent molecular mass
previously found for RESA by SDS-PAGE.
Ultrastructural localisation of the RESA native protein
by immuno-transmission electron microscopy
Immuno-transmission electron microscopy (immuno-
TEM) was used to analyse the ultrastructural localisation of
RESA (Dd2 clone). Whereas all the rabbit antisera pre-
pared against recombinant puriﬁed protein (RESACt)
reacted with ultra-thin sectional material (the PRBC-enri-
ched fraction) containing asexual stages of the Dd2 clone,
the pre-immune serum, used as control, yielded a negative
result. The gold particles were distributed over the infected
Fig. 2 Genetic diversity of
RESA gene by PCR from P.
falciparum genomic DNA. The
position of molecular markers is
indicated on the left (marker
100-pb ladder, Biotools
; M).
Genomic DNA from Equatorial
Guinea isolates (1–6), Nigeria
(8–17) Mali (A, E), Costa de
Marﬁl (B, C), Gabo ´n (D).
Genomic DNA from resistant
clone (Dd2), sensible clone
(3D7). Negative controls (-).
Variation in the size of the
ampliﬁed products was
observed in different isolates
and used clones (3D7 and Dd2)
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123erythrocyte’s surface (Fig. 4), conﬁrming the presence of
the RESA protein of P. falciparum (Dd2 clone). This also
suggests that these antibodies have the potential to recog-
nise the RESA protein of a resistant clone in its natural
form and that they could be used in capture assays for
diagnosis of malaria.
Transmission electron microscopy in ultrathin sections
provides a higher resolution than does scanning electron
microscopy (SEM) and is very useful for studying the inner
subcellular ultrastructure or localisation of molecules. Yet
the amount of speciﬁc epitopes really exposed to reagents
is generally not very high [35].
Expression of GST fusion Pfal-RESACt
The open reading frame of Pfal-RESACt was subcloned
into the pGEX-4T-2 expression vector to produce GST
fusion proteins. Escherichia coli cells (BL21) transformed
with pGEX-4T-2–Pfal-RESACt yielded a single fusion
protein with a molecular mass of about 45 kDa, 19 kDa
corresponding to the carboxyl-terminal fragment of RESA
and 26 kDa to GST. Bacterial cultures transformed with
pGEX-4T-2–Pfal-RESACt were lysed, and fusion proteins
were puriﬁed by afﬁnity chromatography with glutathione
sepharose 4B (Fig. 5). The size obtained for Pfal-RESA
(Dd2 clone) was in agreement with the size of RESA
described for other clones [12].
Antigenicities of P. falciparum
The antigenicity of the RESA fragment was evaluated by
ELISA. When sera from humans clinically immune to
malaria were examined by ELISA for antibodies to
recombinant P. falciparum RESA using Pfal-RESACt as
antigen, the assay’s sensitivity was 78.2%. When the
recombinant protein was tested with sera from patients
with other parasitic diseases, such as leishmaniasis, Chagas
disease and toxoplasmosis, speciﬁcities of 94% were
obtained. In contrast to results with recombinant P. falci-
parum RESA, 0% sensitivities were obtained when the
synthetic peptides (RESA ZR, RESA ZR1, RESA ZR2,
RESA ZR3 and RESA ZR4) were tested with serum
Fig. 3 Western blot of protein extracts of Dd2 clone. Incubation with
1:500 dilution of antiserum from rabbits before immunization (P),
sera from rabbits immunized with the recombinant polypeptide at
1:500 dilution (I). Marker prestained SDS-PAGE Standards, broad
range. Biorad
 (M)
Fig. 4 Ultrastructural
localization of RESA protein in
different stages of P.
falciparum. Transmission
electron microscopy:
immunogold-labelling (10 nm
gold particles, arrows) in ultra-
thin sections. a General
overview of a parasitized
erythrocyte. b The RESA
protein is localized in the
infected erythrocyte’s surface
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123samples from humans clinically immune to malaria. Serum
samples from Spanish donors never exposed to malaria
were used as controls, and none of the human sera recog-
nised GST. It may be signiﬁcant that the highest sensitiv-
ities were detected with recombinant protein, which
contains the carboxy-terminal repeat region of the mole-
cule. This is in line with what other authors previously
described, i.e., in order to identify the main antigenic
determinants of a recombinant P. falciparum glutamate-
rich protein (GLURP), the non-repetitive amino-terminal
region, the central repeat region and the carboxy-terminal
repeat region were produced as separate products and the
antibody response was almost exclusively directed against
the carboxy-terminal repeat region [36]. This immuno-
dominance may be related to the highly repetitive nature of
the carboxy-terminal region [37]. It is very important to
underline the fact that the immunogenic capacity of a
peptide depends, not only on intrinsic chemical properties
of the peptide, but also on many complex interactions with
various elements of the host immune system, such as the
host immunoglobulin repertoire, self-tolerance, and various
cellular and regulatory mechanisms deﬁnable only in the
context of the host [38]. This would explain the failure to
recognise the peptides.
In this study, we found that the human immune response
against RESA is primarily directed against the carboxy-
terminal portion containing the repeat region.
With regard to the effect on parasites, less is known
about antibodies to the non-repeat regions of antigens, such
as Pf 155/RESA. In one study, rabbits were immunised
with synthetic peptides corresponding to three different
non-repeated sequences of the antigen and, though all
antisera reacted strongly with the corresponding synthetic
peptides, they reacted only weakly with full-length pep-
tides [39]. These results indicate that, unlike the ﬁndings
reported by our study, non-repeat sequences of Pf 155/
RESA are immunogenic.
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